全文获取类型
收费全文 | 140624篇 |
免费 | 15006篇 |
国内免费 | 6290篇 |
专业分类
耳鼻咽喉 | 2516篇 |
儿科学 | 1473篇 |
妇产科学 | 2018篇 |
基础医学 | 14629篇 |
口腔科学 | 3671篇 |
临床医学 | 11045篇 |
内科学 | 18981篇 |
皮肤病学 | 2246篇 |
神经病学 | 372篇 |
特种医学 | 6198篇 |
外国民族医学 | 217篇 |
外科学 | 17628篇 |
综合类 | 25814篇 |
现状与发展 | 31篇 |
预防医学 | 3952篇 |
眼科学 | 458篇 |
药学 | 8784篇 |
51篇 | |
中国医学 | 3518篇 |
肿瘤学 | 38318篇 |
出版年
2024年 | 287篇 |
2023年 | 2135篇 |
2022年 | 4154篇 |
2021年 | 6195篇 |
2020年 | 5418篇 |
2019年 | 4804篇 |
2018年 | 4569篇 |
2017年 | 5355篇 |
2016年 | 5995篇 |
2015年 | 6590篇 |
2014年 | 9549篇 |
2013年 | 8748篇 |
2012年 | 8607篇 |
2011年 | 9297篇 |
2010年 | 7380篇 |
2009年 | 7208篇 |
2008年 | 7323篇 |
2007年 | 7794篇 |
2006年 | 7162篇 |
2005年 | 6386篇 |
2004年 | 5091篇 |
2003年 | 4365篇 |
2002年 | 3663篇 |
2001年 | 3452篇 |
2000年 | 2862篇 |
1999年 | 2280篇 |
1998年 | 2067篇 |
1997年 | 1928篇 |
1996年 | 1653篇 |
1995年 | 1379篇 |
1994年 | 1294篇 |
1993年 | 909篇 |
1992年 | 864篇 |
1991年 | 734篇 |
1990年 | 625篇 |
1989年 | 552篇 |
1988年 | 521篇 |
1987年 | 422篇 |
1986年 | 352篇 |
1985年 | 349篇 |
1984年 | 295篇 |
1983年 | 215篇 |
1982年 | 242篇 |
1981年 | 200篇 |
1980年 | 197篇 |
1979年 | 149篇 |
1978年 | 102篇 |
1977年 | 76篇 |
1976年 | 57篇 |
1975年 | 31篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
背景与目的:CD44分子是众多肿瘤细胞的标志分子,其表达水平与肿瘤细胞的恶性程度有关。该研究探讨CD44基因中的单核苷酸多态性(single nucleotide polymorphism,SNP)位点与云南汉族人群宫颈癌和非小细胞肺癌(nonsmall cell lung cancer,NSCLC)易感性的相关性。方法:选取了CD44基因中的两个SNP位点rs13347和rs8193,采用TagMan基因分型的方法,分析这两个多态性位点在497例宫颈癌患者和500例健康对照个体以及483例NSCLC患者和471例健康对照个体中的分布特征,并分析CD44基因中的多态性位点与云南汉族人群宫颈癌和NSCLC的相关性。结果:rs13347和rs8193位点等位基因和基因型在宫颈癌组和对照组中的分布频率的差异无统计学意义(P>0.05)。而在NSCLC组和对照组的比较中:rs13347和rs8193位点等位基因在NSCLC组和对照组中的分布频率的差异有统计学意义(P=0.020和P=0.004);这两个位点基因型在NSCLC组和对照组中分布频率的差异有统计学意义(P=0.027和P=0.020);其中rs13347位点等位基因C在NSCLC组中的分布频率显著高于对照组,可能是NSCLC发生的风险因素(OR=1.250,95% CI:1.035~1.509),rs8193位点等位基因C在对照组中的分布频率显著高于NSCLC组,可能是NSCLC发生的保护性因素(OR=0.768,95%CI:0.641~0.921)。单倍型分析结果显示,rs13347C-rs8193T和rs13347T-rs8193C在NSCLC组和对照组中的分布频率差异有统计学意义(P=0.003和0.022);该结果说明单倍型rs13347C-rs8193T可能是云南汉族人群NSCLC发生的风险性因素(OR=1.316,95%CI:1.096~1.579)。结论:CD44基因中的两个SNP位点rs13347和rs8193可能与云南汉族人群宫颈癌发病风险无关,而可能与云南汉族人群NSCLC具有相关性。 相似文献
43.
44.
肺癌是世界上发病率最高的恶性肿瘤之一,外科手术为首选治疗方式。近年来许多新兴微创技术治疗肺癌取得了良好效果。氩氦冷冻消融术因具有损伤小、恢复快、安全性高、并发症少等优点,已取得医患双方认可。冷冻消融适用于不能手术切除的早期肺癌及减少晚期肺癌负荷。肿瘤是一种全身性疾病,因此冷冻消融联合其他治疗方法将是未来肺癌治疗发展方向,从而改善患者临床症状,提高生活质量,延长生存时间,达到最佳治疗效果。该文就冷冻消融治疗及与其他方法综合治疗肺癌研究现状和进展作一综述。 相似文献
45.
《Journal of vascular and interventional radiology : JVIR》2020,31(1):25-34
PurposeTo investigate the safety of yttrium-90 radioembolization in combination with checkpoint inhibitor immunotherapy for the treatment of hepatocellular carcinoma (HCC).Materials and MethodsThis single-center retrospective study included 26 consecutive patients with HCC who received checkpoint inhibitor immunotherapy within 90 days of radioembolization from April 2015 to May 2018. Patients had preserved liver function (Child-Pugh scores A–B7) and either advanced HCC due to macrovascular invasion or limited extrahepatic disease (21 patients) or aggressive intermediate stage HCC that resulted in earlier incorporation of systemic immunotherapy (5 patients). Clinical documentation, laboratory results, and imaging results at 1- and 3-month follow-up intervals were reviewed to assess treatment-related adverse events and treatment responses.ResultsThe median follow-up period after radioembolization was 7.8 months (95% confidence interval [CI], 5.6–11.8). There were no early (30-day) mortality or grades 3/4 hepatobiliary or immunotherapy-related toxicities. Delayed grades 3/4 hepatobiliary toxicities (1–3 months) occurred in 2 patients in the setting of HCC disease progression. One patient developed pneumonitis. The median overall survival from first immunotherapy was 17.2 months (95% CI, 10.9–23.4). The median overall survival from first radioembolization was 16.5 months (95% CI, 6.6–26.4). From first radioembolization, time to tumor progression was 5.7 months (95% CI, 4.2–7.2), and progression-free survival was 5.7 months (95% CI, 4.3–7.1).ConclusionsRadioembolization combined with checkpoint inhibitor immunotherapy in cases of HCC appears to be safe and causes limited treatment-related toxicity. Future prospective studies are needed to identify the optimal combination treatment protocols and evaluate the efficacy of combination therapy. 相似文献
46.
《The ocular surface》2020,18(4):926-935
PurposeTo visualize and quantify vascular networks in individuals with ocular surface squamous neoplasia (OSSN) through optical coherence tomography angiography (OCTA).MethodCross-sectional study of OSSN patients. Vascular networks were measured by OCTA in the epithelium and sub-epithelial space in the tumors, adjacent tissue, and in the contralateral eye. Vessel area density (VAD, percent of blood vessels within 2.14 mm2), was calculated for each location. Total tumor density (TTD, percent of blood vessels within the entire tumor) was calculated. VAD was assessed separately for corneal and conjunctival locations and compared.ResultsFifteen patients with OSSN were included. The mean age was 61 ± 12 years and the majority were male (80%). The mean tumor area, volume, depth, and TTD were 28.0 ± 9.0 mm2 (range, 10.9–39.7), 9.1 ± 4.1 mm3 (range, 3.4–18.8), 334 ± 125 μm (range, 177–571), and 33.2% ± 11.0% (range, 18.7–58.8), respectively. The VAD was highest within the tumor (28.9% ± 8.7%) followed by the adjacent sub-epithelial tissue and the tissue underneath the conjunctival component of tumor. These densities were higher than the VAD in the tissues of the non-involved eye (all P < 0.05). The VAD within conjunctival component of tumor was significantly higher than those with corneal component (29.8% ± 9.5% vs. 21.1% ± 5.5%, p = 0.006). The VAD under conjunctival tumor was also significantly higher than under corneal component (24.1% ± 7.8% vs. 17.0% ± 6.1%, p = 0.024).ConclusionsOCTA imaging allowed for visualization and quantification of vessel structure and density within, under, and surrounding OSSN. 相似文献
47.
48.
Seven patients with advanced lateral oropharyngeal cancer (T3N2bM0, or T4N2bM0) underwent transoral lateral oropharyngectomy (TLO) with reconstruction performed through set-back tongue flap and polyglycolic acid (PGA) sheet. TLO was performed following en bloc resection of tumors using endoscopy. To cover the resulting defect in the lateral oropharyngeal wall, the set-back tongue flap was moved posteriorly and laterally to the area of the tongue base and lateral pharyngeal wall. The tip of the set-back tongue flap was sutured to the lateral pharynx to reconstruct the elevated tongue base and altered anterior pillar. The defect on the floor of the mouth was reconstructed using a PGA sheet. Following surgery, the mean observation period was 24 months. The mean operating time was 4 h and 2 min, with an average blood loss of 68.1 ml. All oral intake resumed on the first postoperative day via gastric tube. The mean gastric tube removal time was 1.6 postoperative days as a result of sufficient oral intake. None of the patients received postoperative radiotherapy or displayed evidence of tumor recurrence. We conclude that this novel procedure is highly effective for treating advanced oropharyngeal cancer as it demonstrates good prognostic and functional outcomes. 相似文献
49.
50.